Camlin Fine Sciences Ltd
NSE:CAMLINFINE
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
86.95
137.8
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Camlin Fine Sciences Ltd
Camlin Fine Sciences Ltd
Cost of Revenue
Camlin Fine Sciences Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Camlin Fine Sciences Ltd
NSE:CAMLINFINE
|
Cost of Revenue
-₹9.2B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-30%
|
|
|
Akzo Nobel India Ltd
NSE:AKZOINDIA
|
Cost of Revenue
-₹22.3B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Navin Fluorine International Ltd
NSE:NAVINFLUOR
|
Cost of Revenue
-₹9.9B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Asian Paints Ltd
NSE:ASIANPAINT
|
Cost of Revenue
-₹200B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-10%
|
|
|
Gujarat Fluorochemicals Ltd
NSE:FLUOROCHEM
|
Cost of Revenue
-₹23.6B
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Vinati Organics Ltd
NSE:VINATIORGA
|
Cost of Revenue
-₹12B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-10%
|
|
Camlin Fine Sciences Ltd
Glance View
Camlin Fine Sciences Ltd. engages in the research, development, manufacture, and marketing of fine chemicals which are used as antioxidants, industrial chemicals, and aroma products. The company is headquartered in Mumbai, Maharashtra and currently employs 478 full-time employees. The company went IPO on 2015-01-20. The firm is a provider of antioxidants and shelf-life solutions, aroma ingredients, health and wellness, and performance chemicals. Its products include BHA, TBHQ and GUAIACOL BULK. The firm offers its products across various industries, including food and beverages, animal nutrition, pet food, aquaculture, bio-fuels, pharmaceuticals, dyes and pigments, petrochemicals and polymers. The company manufactures Methyl Vanillin which is sold under the Company’s brand name VanesseTM and Ethyl Vanillin, that is used in a range of applications, such as chocolates, ice creams, bakery products, incense sticks, perfumes, soaps, personal care and cosmetic products. Its performance chemicals business is involved in providing specialty chemicals, including Guaiacol, Veratrole, TBC, MEHQ, CME, HQEE, Hydroquinone and Catechol.
See Also
What is Camlin Fine Sciences Ltd's Cost of Revenue?
Cost of Revenue
-9.2B
INR
Based on the financial report for Jun 30, 2024, Camlin Fine Sciences Ltd's Cost of Revenue amounts to -9.2B INR.
What is Camlin Fine Sciences Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-30%
Over the last year, the Cost of Revenue growth was -8%. The average annual Cost of Revenue growth rates for Camlin Fine Sciences Ltd have been -15% over the past three years , -12% over the past five years , and -30% over the past ten years .
You don't have any saved screeners yet
